Hydrocortisone suppositories are indicated for use in: inflamed hemorrhoids post-irradiation (factitial) proctitis as an adjunct in the treatment of chronic ulcerative colitis cryptitis other inflammatory conditions of anorectum and pruritus ani.
Dosage and administration
For Rectal administration. OPENING INSTRUCTIONS Separate plastic film at top opening and pull downward. Continue pulling downward to almost the full length of the suppository. Gently remove the suppository from the film pocket Avoid excessive handling of the suppository which is designed to melt at body temperature. Insert suppository into the rectum with gentle pressure, pointed end first. Insert one suppository ...
Storage and handling
Store at 20º-25ºC (68º-77ºF) [See USP Controlled Room Temperature]. Excursions permitted to 15º- 30ºC (59º-86ºF). Store away from heat. Protect from freezing
Hydrocortisone acetate suppositories 25mg For Rectal Administration Rx Only
DESCRIPTION:
DESCRIPTION SECTION
Hydrocortisone acetate is a corticosteroid designed chemically as pregn-4-ene 3, 20-dione, 21- (acetyloxy)-11, 17-dihydroxy––(11 β) with the following structural formula:
structural formula
Each rectal suppository contains hydrocortisone acetate, USP 25 mg in a specially blended hydrogenated vegetable oil base.
CLINICAL PHARMACOLOGY:
CLINICAL PHARMACOLOGY SECTION
In normal subjects, about 26% of hydrocortisone acetate is absorbed when the suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed surfaces. Topical steroids are primarily effective because of their anti-inflammatory, anti-pruritic and vasoconstrictive action.
INDICATIONS AND USAGE:
INDICATIONS & USAGE SECTION
Hydrocortisone suppositories are indicated for use in:
inflamed hemorrhoids
post-irradiation (factitial) proctitis
as an adjunct in the treatment of chronic ulcerative colitis
cryptitis
other inflammatory conditions of anorectum and pruritus ani.
CONTRAINDICATIONS:
CONTRAINDICATIONS SECTION
Hydrocortisone suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components.
PRECAUTIONS:
PRECAUTIONS SECTION
Do not use Hydrocortisone suppositories unless adequate proctologic examination is made. If irritation develops, the product should be discontinued and appropriate therapy instituted. In the presence of an infection, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, Hydrocortisone suppository should be discontinued until the infection has been adequately controlled.
Carcinogenesis:
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION
No long term studies in animals have been performed to evaluate the carcinogenic potential of corticosteroid suppositories.
Pregnancy Category C:
PREGNANCY SECTION
In laboratory animals, topical steroids have been associated with an increase in the incidence of fetal abnormalities when gestating females have been exposed to rather low dosage levels. There are no adequate and well controlled studies in pregnant women. Hydrocortisone suppositories should only be used during pregnancy if the potential benefit justifies the risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.
It is not known whether this drug is excreted in human milk and because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Hydrocortisone suppositories, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother
ADVERSE REACTIONS:
ADVERSE REACTIONS SECTION
The following local adverse reactions have been reported with corticosteroid suppositories; burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis, secondary infection.
To report suspected adverse reactions, Contact NEOMED pharmaceutical or www.fda.gov/medwatch
DRUG ABUSE AND DEPENDENCE:
DRUG ABUSE AND DEPENDENCE SECTION
Drug abuse and dependence have not been reported in patients treated with Hydrocortisone suppositories.
OVERDOSAGE:
OVERDOSAGE SECTION
If signs and symptoms of systemic over dosage occur, discontinue use.
DOSAGE AND ADMINISTRATION:
DOSAGE & ADMINISTRATION SECTION
For Rectal administration.
OPENING INSTRUCTIONS
Separate plastic film at top opening and pull downward.
Continue pulling downward to almost the full length of the suppository.
Gently remove the suppository from the film pocket
Opening Instruction
Avoid excessive handling of the suppository which is designed to melt at body temperature. Insert suppository into the rectum with gentle pressure, pointed end first. Insert one suppository in the rectum twice daily, morning and night for two weeks, in nonspecific proctitis. In more severe cases, one suppository three times a day or two suppositories twice daily. In factitial proctitis, the recommended duration of therapy is six to eight weeks or less, according to the response of the individual case.
All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable.
PLEASE NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic or other equivalency testing. No representation is made as to generic status or bio equivalency. Each person recommending a prescription substitution using this product shall make such recommendation based on his/her professional knowledge and opinion, upon evaluating the active ingredients, inactive ingredients, excipients and chemical information provided herein.
HOW SUPPLIED:
HOW SUPPLIED SECTION
Hydrocortisone acetate suppositories 25mg are off-white, smooth surfaced and bullet shaped with one pointed end.
Box of 12 suppositories, NDC 70898-102-12
STORAGE:
STORAGE AND HANDLING SECTION
Store at 20º-25ºC (68º-77ºF) [See USP Controlled Room Temperature]. Excursions permitted to 15º- 30ºC (59º-86ºF). Store away from heat. Protect from freezing
Other Information
SPL UNCLASSIFIED SECTION
Manufactured for: NEOMED PHARMACEUTICAL BRENTWOOD, NY 11717
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.